These effects are partly thought to be caused by increased calcium retention caused by increased FGF23 and PTH concentrations [62], together with elevated aldosterone concentrations found in CKD patients due to activation of the Renin–Angiotensin–Aldosterone System (RAAS) [63]. This evidence concerns the gene REN and chronic kidney disease.